Vanguard Personalized Indexing Management’s Sana Biotechnology SANA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$79.1K	Buy	22,654 +1,022	+5%	+$3.29K	﹤0.01%	2084
2026 Q1	$62.3K	Buy	21,632 +1,453	+7%	+$5.72K	﹤0.01%	2020
2025 Q4	$82.1K	Sell	20,179 -14	-0.1%	-$63	﹤0.01%	1834
2025 Q3	$71.7K	Buy	20,193 +508	+3%	+$1.84K	﹤0.01%	1864
2025 Q2	$53.7K	Buy	19,685 +1,527	+8%	+$3.15K	﹤0.01%	1817
2025 Q1	$30.5K	Sell	18,158 -36	-0.2%	-$101	﹤0.01%	1726
2024 Q4	$29.7K	Buy	+18,194	New	+$54.3K	﹤0.01%	1740

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Vanguard Personalized Indexing Management's SANA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Sana Biotechnology (SANA) stake by 4.7% in Q2 2026, buying an estimated $3.29K and bringing the position to 22,654 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2084.

Vanguard Personalized Indexing Management first reported a position in SANA in Q4 2024 and has held it in 7 quarters since. The position peaked at $82.1K in Q4 2025. 212 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Vanguard Personalized Indexing Management held 22,654 shares of Sana Biotechnology worth $79.1K as of Q2 2026.
Vanguard Personalized Indexing Management bought 1,022 Sana Biotechnology shares in Q2 2026, an estimated $3.29K.
Sana Biotechnology made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2084 holding.
Vanguard Personalized Indexing Management first reported a position in Sana Biotechnology in Q4 2024 and has held it in 7 quarters since.
Vanguard Personalized Indexing Management's Sana Biotechnology position peaked at $82.1K in Q4 2025.
212 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.